Teleflex Incorporated Teleflex Incorporated

Teleflex Incorporated

TFX

Kedudukan dalam Saham #3220
Teleflex Incorporated is a global medical technology company dedicated to... Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.
Harga Saham
$130.40
Modal Pasaran
$5.53B
Perubahan (1 hari)
0.63%
Perubahan (1 tahun)
-0.11%
Negara
US
Perdagangan Teleflex Incorporated (TFX)

Kategori

Healthcare
Nisbah P/E bagi Teleflex Incorporated (TFX)
Nisbah P/E pada October 2026 TTM: -5.30
Menurut laporan kewangan dan harga saham terkini Teleflex Incorporated, nisbah P/E semasa (TTM) ialah -5.30. Pada akhir 2023, syarikat mempunyai nisbah P/E sebanyak 32.87.
Sejarah nisbah P/E bagi Teleflex Incorporated dari 2000 hingga 2026
Nisbah P/E pada akhir setiap tahun
Tahun Nisbah P/E Ubah
2026 (TTM) -5.30 -104.43%
2024 119.64 263.93%
2023 32.87 1.97%
2022 32.24 1.85%
2021 31.65 -44.52%
2020 57.06 51.40%
2019 37.69 -35.92%
2018 58.81 -19.89%
2017 73.41 149.60%
2016 29.41 31.84%
2015 22.31 -11.85%
2014 25.31 -1.03%
2013 25.57 -266.80%
2012 -15.33 -299.68%
2011 7.68 -28.10%
2010 10.68 51.16%
2009 7.06 -57.34%
2008 16.56 -1.95%
2007 16.89 -8.27%
2006 18.41 -3.49%
2005 19.08 -91.25%
2004 218.11 1,134.01%
2003 17.68 32.21%
2002 13.37 -18.05%
2001 16.31 5.58%
2000 15.45 0.00%
Nisbah P/E untuk syarikat serupa atau pesaing
Syarikat Nisbah P/E Perbezaan Nisbah P/E Negara
47.48 -996.61%
US
27.43 -617.86%
FR
- -
JP
56.89 -1,174.29%
US
- -
CH
Cara membaca nisbah P/E

Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.

Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.

Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.